Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Sarolaner

    • Product Name Sarolaner
    • Alias Simparica
    • Einecs 939-727-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    165078

    Active Ingredient Sarolaner
    Drug Class Isoxazoline
    Primary Use Ectoparasiticide
    Target Species Dogs
    Formulation Chewable tablet
    Mechanism Of Action GABA and glutamate receptor antagonist in parasites
    Effectiveness Against Fleas and ticks
    Prescription Required Yes
    Typical Dosage Once monthly
    Brand Name Simparica

    As an accredited Sarolaner factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Sarolaner features a sealed, amber glass vial containing 10 grams of white crystalline powder, labeled with safety information.
    Shipping Sarolaner is shipped in accordance with standard regulatory guidelines for chemical products. It is securely packaged in sealed containers, clearly labeled, and protected from moisture, heat, and direct sunlight. Handling precautions, safety data sheets, and relevant documentation are included to ensure safe and compliant transportation to the destination.
    Storage Sarolaner should be stored in a tightly sealed container at room temperature, typically between 20°C to 25°C (68°F to 77°F), and protected from moisture, light, and excessive heat. The storage area should be dry and well-ventilated, with access restricted to authorized personnel. Keep Sarolaner out of reach of children and animals to prevent accidental ingestion.
    Application of Sarolaner

    Applications of Sarolaner in Industrial Manufacturing

    Sarolaner, developed for targeted control of ectoparasites, supports critical manufacturing processes within the veterinary pharmaceutical sector. As the original manufacturer, we supply Sarolaner to clients who formulate advanced antiparasitic products for companion animals, maintaining rigorous quality, safety, and regulatory benchmarks across all downstream applications. The following sections detail established industrial scenarios, reflecting the real methods and controls used by manufacturers worldwide.

    1. Oral Chewable Tablet Formulations for Canine Ectoparasite Control

    Veterinary pharmaceutical manufacturers incorporate Sarolaner into oral tablet production lines, focusing on flea and tick prevention for dogs. Integration into palatable chewable formats requires precise granulation and controlled blending to ensure consistent dosing and compliance with pet health authority regulations. End products undergo stringent release checks to confirm uniformity in active content and tableting properties prior to packaging for market.

    Industry compliance standards

    • European Pharmacopoeia (Ph. Eur.) Monograph 5.2.10 (Veterinary substances)
    • US FDA Center for Veterinary Medicine (CVM) Guidance for Industry, including cGMP (21 CFR Part 211)
    • VICH GL9: Good Clinical Practice
    • EMA/CVMP Quality Guidelines for Veterinary Pharmaceutical Products

    Typical usage ratio

    • 0.5–2.5% w/w of core tablet composition, dosage adjusted based on target dog weight bracket (0.5–2.0 mg/kg body weight dosing)

    Downstream process integration

    • Direct blending into tableting granulate; critical quality attribute testing for homogeneity after mixing and prior to compression
    • Final tableting performed with rotary tablet presses under controlled environmental conditions

    Final product types

    • Palatable oral chewables (monthly flea and tick tablets)
    • Film-coated veterinary tablets
    • Veterinary prescription single-dose packs

    2. Topical Solutions and Spot-On Treatments in Companion Animal Health

    Sarolaner is utilized by manufacturers in the production of topical, spot-on antiparasitic preparations for cats and dogs. Downstream operations require dissolution in medical-grade solvents and fine emulsifiers, often as part of multi-active ingredient formulations, to maximize skin absorption and residual activity against parasites. All batches undergo detailed stability and residue testing to meet regional veterinary medicine laws.

    Industry compliance standards

    • Veterinary Medicines Directorate (VMD, UK) GMP for Externally Applied Veterinary Medicines
    • OECD Guidelines on Residue Studies (No. 504 & 509)
    • European Pharmacopoeia 5.0.3 (Dermal veterinary medicinal products)
    • US FDA CVM Guidance on Topical Applications

    Typical usage ratio

    • 0.1–0.3% w/v final solution (applied at approximately 1–4 mg/kg, regimen defined by companion animal species and regional requirements)

    Downstream process integration

    • Solubilization into carrier oil blends via high-shear mixing tanks prior to aseptic filling
    • Filtration followed by dispensing into precision single- or multi-dose applicators
    • Quality assurance confirmation for content uniformity and droplet consistency

    Final product types

    • Spot-on pipettes for household pets (canine and feline lines)
    • Multi-active external parasite control solutions
    • Veterinary-labeled monthly application packs

    3. Combination Formulations with Other Isoxazolines for Extended Spectrum

    Pharmaceutical producers commonly formulate Sarolaner in synergistic blends with other isoxazoline actives—such as afoxolaner or lotilaner—to widen protection against fleas, ticks, and certain mites. Manufacturers must ensure exact dosing fidelity and compatibility throughout co-formulation, employing advanced blend validation and stability protocols in accordance with combination veterinary product regulations.

    Industry compliance standards

    • VICH GL43: Stability Testing of New Veterinary Drug Substances and Medicinal Products
    • EU Regulation (EC) No 726/2004 for Combination Veterinary Pharmaceuticals
    • Veterinary International Conference on Harmonization (VICH)
    • Japan Ministry of Agriculture (MAFF) Veterinary Drug Approval Standards

    Typical usage ratio

    • Each active generally 0.5–2% w/w per tablet or dosage unit, titrated based on intended parasite spectrum and animal weight class; ratio adjustments validated during multi-active development

    Downstream process integration

    • Multi-step blending: each API pre-milled then batch-mixed under closed systems to maintain uniformity and avoid cross-reactivity
    • Continuous in-line sampling for content uniformity across blends
    • Final compression or filling after validated homogeneity

    Final product types

    • Dual- or triple-active veterinary oral tablets
    • Chewable tablets for broad-spectrum parasite control
    • Blister-packed veterinary pharmaceuticals (combination products)

    4. Injectable Formulations for Clinical Veterinary Practice

    Although less common than oral and topical routes, several veterinary pharma firms have scaled up the manufacture of injectable solutions based on Sarolaner, mainly for specific clinical indications where rapid or forced administration is necessary (e.g., severe infestations in shelter or farm settings). This requires careful solubilization in biocompatible, preservative-free carriers and aseptic process controls, with rigorous batch testing for sterility and particulate content. Distribution channels primarily serve licensed veterinary practitioners.

    Industry compliance standards

    • USP 788 (Particulate Matter in Injections)
    • US FDA Guidance for Sterile Drug Products (cGMP Processes)
    • European Pharmacopoeia 2.6.1 (Sterility Testing)
    • WHO Good Manufacturing Practices (GMP) for Sterile Pharmaceutical Products

    Typical usage ratio

    • 0.05–0.2% w/v in injectable preparations, modulated according to species-specific dose volume and therapeutic protocol

    Downstream process integration

    • Direct dissolution into pre-filtered sterile carrier solutions (e.g., saline, PEG-based systems) under laminar flow
    • Final aseptic filtration (0.22 μm) and gamma or terminal sterilization ahead of filling into vials or syringes
    • QC includes sterility, content, and particulate testing per release batch

    Final product types

    • Single-use sterile injectable vials for veterinary prescription
    • Multi-dose sterile veterinary ampoules
    • Ready-to-use syringes for emergency parasite intervention

    5. Research and Reference Standards for Quality Control Laboratories

    Pharmaceutical industry laboratories and quality control (QC) services regularly source Sarolaner as a high-purity reference substance for calibration, impurity profiling, and ongoing batch verification in downstream finished product plants. We offer precision-characterized lots suitable for analytical use, supporting method validation and regulatory submissions. Proper handling, documentation, and traceability are included in all supply batches.

    Industry compliance standards

    • ICH Q6A: Specifications for New Drug Substances and Products (Veterinary)
    • USP Reference Standards General Notice
    • ISO/IEC 17025:2017 (Testing and Calibration Laboratories)
    • Ph. Eur. General Chapters—Reference Standards

    Typical usage ratio

    • 5–50 mg per standard lab operation (determined by method sensitivity and sample throughput)

    Downstream process integration

    • Direct weighing and dilution for analytical test development: HPLC assay, residual solvent analysis, dissolution studies
    • Inclusion in stability and release protocols for routine finished-goods batch testing

    Final product types

    • Certified reference standard sets for in-house QC/QA labs
    • Analytical control samples for validation of veterinary medicine batches
    • Working standards provided to contract testing laboratories
    Free Quote

    Competitive Sarolaner prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Taking a Close Look at Sarolaner: A Modern Approach to Parasite Protection

    Why Sarolaner Draws Attention in Pet Care

    Sarolaner has emerged as a bit of a game changer in the push for safer, more effective parasite prevention in pets. Anyone with a dog or cat knows the tightrope walk of choosing flea and tick protection—one that lasts, works fast, and doesn’t cause harm, especially when asking a vet or researching options on your own. Sarolaner stands out in a crowded market of isoxazoline products; the difference is not just its name or flashy packaging. Here’s where things genuinely change for pet owners: Sarolaner brings peace of mind, a once-a-month chewable dose, and a track record veterinarians are coming to trust.

    What Sets Sarolaner Apart from Flea and Tick Control of the Past

    For years, pet owners relied on older collars, dips, sprays, or monthly spot-on treatments. These approaches carry their own set of headaches: messy application, a window for missed doses, and, occasionally, a lingering worry about side effects. Sarolaner moves away from all that. The chewable tablet provides oral prevention, which helps avoid accidental contact with children or other animals and skips the oily residue that sometimes attracts dust on a pet’s coat. It doesn’t hurt that most dogs treat these tablets as treats, making monthly dosing less of a chore for everyone involved.

    Sarolaner targets the nervous system of parasites with high selectivity, meaning it disrupts flea and tick function without crossing over into harmful territory for mammals at prescribed doses. Published in peer-reviewed journals, this selectivity keeps showing up as a key advantage. While other chemicals may get the job done, some pets run into issues with skin reactions or even neurological side effects. Sarolaner’s chemical design has specifically focused on reducing those risks. In practical terms, I’ve seen nervous dog owners breathe easier knowing their pet’s medication handles infestations without triggering more problems than it solves.

    Getting Down to Usage: How Real Life Experience Shapes Perspective

    I remember my first go-round helping a friend treat his rescue pup. The dog’s coat thinned and she constantly scratched—classic sign of fleas. The vet spelled out the protocol: a quick-acting, long-lasting chewable. Sarolaner entered the mix. Within a day, dead fleas began dropping off, and the scratching calmed down. It wasn’t just a lucky break; studies confirm fleas start dying off within hours after the first dose, and infestations can drop off entirely with proper monthly use.

    For ticks, the struggle can feel like a losing battle in certain regions—lots of tall grass, temperate climates, maybe even a rise in local tick-borne diseases. Sarolaner stacks up well, maintaining a consistent kill rate for most tick species common in pets’ environments. This matters, since ticks don’t just annoy—they transmit pathogens like Lyme disease and ehrlichiosis. Quick kill times mean less opportunity for infection, and this is where Sarolaner earns its keep. Pet owners can go on more worry-free hikes and play in the backyard with far fewer tick checks required.

    The Actual Tablet: Specs and Administration

    A look at Sarolaner’s delivery method reveals its practicality. Instead of a messy topical, the active ingredient comes in beef-flavored tablets, sized according to the weight of the pet. Dosing is straightforward, usually one tablet, once per month. These chewables often have flavoring and binders to appeal to pets. In practice, even picky eaters rarely refuse them, especially when introduced with a reward or regular meal. It makes all the difference for people managing multiple pets or aiming to stick to a routine.

    One tablet covers fleas and ticks for an entire calendar month. In studies and field reports, the active compound gets absorbed in the gut and travels into the bloodstream, meaning it acts at the site where parasites bite. Fleas jumping on a treated animal don’t get a chance to lay eggs; existing infestations get shut down fast. It’s not about killing every parasite on contact in the environment—Sarolaner relies on parasitic feeding behavior, so animals still need short exposures in infested areas before seeing the benefit. This is a tradeoff most owners accept, especially when compared to treatments that leave oily patches or irritate skin.

    The Practical Benefit: What Pet Owners Actually Notice

    One thing no pamphlet or marketing claim replaces is the feel of a dog’s healthy coat or seeing a cat relaxed and content instead of clawing at itchy, irritated skin. Sarolaner doesn’t claim to be a miracle fix for every pet, but it addresses the main frustrations: eliminating persistent flea cycles, controlling ticks before problems start, and fitting seamlessly into daily routines. Some alternatives run the risk of leaving “gaps”—periods before reapplication where fleas start returning—especially with missed topical doses or pets swimming a lot. Oral dosing gets rid of this uncertainty, and the once-monthly interval lines up well with regular vet checkups or grooming habits.

    From a safety standpoint, the real-world reports align well with published research. Most animals tolerate Sarolaner with few complaints. Like any medicine, there’s always outlier cases, but overall adverse events stay rare. The peace of mind for owners—knowing the product works inside the animal and doesn’t leave residue around the house—goes a long way, especially for families with kids.

    Sarolaner Compared to Other Isoxazoline-Based Options

    In a market crowded with isoxazoline-based preventives, Sarolaner carves out a clear space. Other products in this class—like afoxolaner and fluralaner—bring strong reputations for effectiveness, but the differences aren’t just technical. A key distinction shows up in the duration and spectrum of effectiveness. Where some competitors stretch a single dose to cover two or three months, Sarolaner aims for high, reliable coverage over a single month. Supporters point out that this approach makes it easier to catch up if a dose gets missed, keeping the pet protected more consistently.

    Some owners prefer a longer re-dose interval for convenience, but shorter intervals can actually improve compliance. Memory fades, routine changes crop up, and before you know it, prevention lapses and infestations return. Monthly dosing, especially when it comes in a treat, fits more naturally into most lifestyles. Plus, Sarolaner’s broad tick coverage is often cited as a notch above, protecting against several tick species some other products may only partially target.

    Safety is another major talking point. Isoxazolines have prompted headlines and even regulatory warnings in the past, especially for pets with a known history of seizures or neurological issues. Sarolaner sits in a position backed by multiple peer-reviewed studies, showing favorable safety and tolerability at recommended dosages. While no medication is completely free from possible side effects, ongoing monitoring has built up trust over years, both in clinics and among everyday owners.

    Looking at Broader Impact: Flea and Tick Resistance

    A looming worry in the world of parasite control is resistance: over time, parasites exposed to the same chemical group can start to shrug it off. It shows up in agriculture, and now veterinarians keep an eye on the pet market the same way. Sarolaner, as a relative newcomer, faces less resistance than some older compounds, and laboratories keep tabs through field surveillance and genetic testing. Pet owners don’t always see this playing out directly, but the ripple effect matters. Sticking to a well-managed product rotation and proper dosing schedule lowers the chance of resistance creeping into communities—a real shared responsibility among professionals and pet lovers alike.

    Ease and Flexibility: How Sarolaner Fits into Veterinary Practice

    Talk to any veterinary technician juggling appointments, and you’ll hear the same story: the easier a product makes their job, the more likely it is to be recommended and adopted. Sarolaner’s one-tablet per month regimen means less confusion about dosing, fewer missed treatments, and happier clients. Some products require complex calculations based on changing pet weights, but Sarolaner keeps things simple with clearly marked sizes. This straightforward approach lightens the load during busy appointment days and keeps things moving fast in the exam room.

    For homes with more than one animal, the logistics of keeping everyone on the same prevention protocol can feel like spinning plates. Owners battling a flea infestation sometimes have to treat every animal in the household without missing a beat. The consistency and palatability of Sarolaner make these “all-pet” treatments manageable. There’s less balking, wasted doses, or complications from pets licking each other. That’s a big improvement for anyone who’s wrestled a pill into a reluctant cat or cleaned up after a failed topical application.

    The Bottom Line for Pet Owners: Peace of Mind and Proven Science

    For many, the true worth of Sarolaner shows up not in lab graphs or sales numbers, but in the calm that follows a month without scratching, the comfort of knowing pets can roam safely, and the everyday reality of hunkering down with a healthy, relaxed animal at home. Sarolaner’s design, delivery method, and proven record place it among the most reliable tools in modern parasite prevention.

    The evidence speaks for itself: pets protected with Sarolaner live freer of the discomfort and danger posed by fleas and ticks, while owners wrestle less with the headaches that so often come from complicated or outdated treatments. Sarolaner stands out as a product designed to fit real lives, streamline daily routines, and provide a modern answer to challenges pet owners have faced for generations.

    Solutions to Common Barriers

    Pet owners face a few common roadblocks when using any parasite preventive: remembering monthly dosing, recognizing the signs of breakthrough infestations, and understanding the risks involved in skipping doses. Relying on Sarolaner’s chewable format and its palatability can help solve the problem of missed doses. Marking calendars, setting phone reminders, and including the medication with monthly grooming or vet appointments improves compliance.

    For those worried about medication sensitivity, open conversations with veterinarians remain essential. Monitoring for side effects, especially in breeds known for neurological sensitivities, ensures animals stay safe. Sarolaner’s safety profile gives most owners relief, but extra caution never hurts in special cases.

    Veterinarians also stress rotating products in long-term high-risk environments, both to avert local resistance and to ensure maximum protection over time. Trusted veterinary sources often recommend coupling Sarolaner with comprehensive pest management—a clean home environment, frequent bedding changes, and targeted yard treatment—to break the flea or tick life cycle.

    Bringing It All Together

    Sarolaner isn’t a miracle drug, but it represents a meaningful step forward in the effort to make parasite protection safer, easier, and more reliable. Its monthly oral dose, high selectivity, and broad protection keep it on the shortlist for both busy veterinary practices and households that want fewer worries. For those of us who know the late-night sound of a dog losing sleep over itchy bites, or have chased a cat under the couch with a tube of messy medication, this progress is more than welcome—it’s a chance for pets (and people) to rest easier, season after season.